ReviewMedical science monitor : international medical journal of experimental and clinical research2024
Enhanced Diagnostic Imaging: Arrival-Time Parametric Imaging in Contrast-Enhanced Ultrasound for Multi-Organ Assessment.
Review in Medical science monitor : international medical journal of experimental and clinical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Hepatic microperfusion in acute cold exposure: Dual-modality study using contrast-enhanced ultrasound and CT perfusion imaging.iScience · 2026Article
- Evaluation of endometrial perfusion by arrival time parametric imaging using contrast-enhanced ultrasonography in patients with intrauterine adhesions.Quantitative imaging in medicine and surgery · 2026Article
- Microvascular Imaging of Hepatic Hemangiomas.Diagnostics (Basel, Switzerland) · 2025Article
- Advances in the clinical diagnosis of lung cancer using contrast-enhanced ultrasound.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contrast-enhanced ultrasonography (CEUS) is a novel technology in ultrasound medicine that has gained widespread application in clinical practice. While CEUS offers various quantitative and qualitative parameters, it is limited by factors such as the single-color transient coverage of the contrast agent and its dependence on the operator, rendering it less suitable for detecting blood in organ lesions. Additionally, fluid dynamic perfusion remains unsatisfactory. Recently, arrival-time parametric imaging (At-PI) has emerged as a promising alternative; this technology not only uses color overlay to statically represent the dynamic perfusion of blood flow within lesions but also enhances visualization, minimizes operator variability, and provides insights into the vascular patterns of both benign and malignant lesions. At-PI has demonstrated numerous advantages and has been successfully applied to the liver, adrenal gland, breast, lymph nodes, prostate, and gastrointestinal tract, yielding encouraging preliminary results. This review synthesizes existing research findings, highlights significant parameters, examines the current global research landscape regarding this technology, and outlines the research directions pursued by scholars in the field. Furthermore, we offer a critical analysis and discussion of the limitations of these findings. The ultimate aim is to elucidate the role of At-PI in clinical diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.